NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous applications.

Your blood is constantly renewed by a hidden army—hematopoietic stem cells in your bone marrow. These cells can create every type of blood cell, but new research shows some are surprisingly picky, ...

To study the genetic causes of autism spectrum disorder, a Kobe University research team has created a bank of 63 mouse embryonic stem cell lines containing the mutations most strongly associated with ...

Hypertrophic cardiomyopathy, or HCM, is a common but potentially lethal heart disease. While researchers have tried for decades to understand the contribution of the many genes linked to the condition ...

A coalition of anti-abortion legislators is calling for an end to human embryonic stem cell research at the National ...

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...

These factors prompted research into better and more permanent treatments for T1D. The most obvious solution: restore the natural repertoire of β cell islets. Although most recipients experienced ...